Overview

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Status:
Completed
Trial end date:
2019-07-22
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effectiveness of exenatide in adults experiencing episodes of hyperinsulinemic hypoglycemia following Roux-en-Y bariatric surgery.
Phase:
Phase 1
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Acarbose
Exenatide